OXEIA BIOPHARMACEUTICALS
Oxeia Biopharmaceutical soperates in the healthcare industry focusing on pharmaceutical business. According to the Centers for Disease Control, 2.2 million cases of mild traumatic brain injury (concussions) are seen in US hospital emergency rooms every year. Other estimates suggest 4 – 5 million concussions to be more accurate if unreported events are also considered. Research in the last two decades has increasingly linked concussions to neurodegenerative conditions including dementia, Alzheimer’s disease, and chronic traumatic encephalopathy (CTE).
OXEIA BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.oxeiabiopharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
310 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit Squarespace
Similar Organizations
Splash Pharmaceuticals
Splash Pharmaceuticals is a clinical stage oncology company.
Current Employees Featured
Founder
Investors List
Tech Coast Angels
Tech Coast Angels investment in Venture Round - Oxeia Biopharmaceuticals
Official Site Inspections
http://www.oxeiabiopharma.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Oxeia Biopharmaceuticals"
Oxeia Biopharmaceuticals
Oxeia Biopharmceuticals 361 Newbury Street Suite 500 Boston, MA 02115. [email protected]See details»
Oxeia Biopharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Oxeia Biopharmaceutical soperates in the healthcare industry focusing on pharmaceutical business. According to the Centers for Disease Control, …See details»
Leadership Team - Oxeia Biopharmaceuticals
Amit Munshi is an experienced pharmaceutical executive and Co-founder of Oxeia Biopharmaceuticals, Inc. Mr. Munshi is the Chief Executive Officer of ReNAgade Therapeutics, …See details»
Oxeia Biopharmaceuticals Inc | LinkedIn
Oxeiabiopharma.com 29 9 Comments Like Comment Share Oxeia Biopharmaceuticals Inc 282 followers 11mo Report this post Oxeia is excited to share the potentially game-changing results of a Phase 2a ...See details»
Oxeia Biopharmaceuticals - Overview, News & Similar companies ...
Oxeia Biopharmaceuticals has announced that Julianne Averill has joined the organization as Chief Financial Officer. ... Phone number: (617) 991-9150 Website: www.oxeiabiopharma.com …See details»
Oxeia Biopharmaceuticals Announces Clinical Advancement Of …
Aug 2, 2017 Please visit www.oxeiabiopharma.com for more information and contact details. ... nonprofit organization located in Boston. It was founded in 2007 by Robert Cantu, MD, and …See details»
OXEIA BIOPHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OXEIA BIOPHARMACEUTICALS, INC. of Boston, MA. Get the latest business insights from Dun & …See details»
Oxeia Biopharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Oxeia Biopharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND …
BOSTON, Jan. 20, 2022 /PRNewswire/ -- Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today …See details»
Advisory Board - Oxeia Biopharmaceuticals
Chris Nowinski is the co-founder and CEO of the Concussion Legacy Foundation (CLF), a non-profit organization dedicated to solving the sports concussion crisis through education, policy, …See details»
Oxeia Biopharmaceuticals - Craft
Oxeia Biopharmaceuticals is a biotech company developing drug treatments for concussion and underlying neuro-metabolic dysfunction. Its lead program, OXE-103, is a potent mitochondrial …See details»
Oxeia Biopharmaceuticals, Inc. Announces Initiation Of Phase 2 …
SAN DIEGO, Oct. 21, 2020 /PRNewswire/ -- Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro …See details»
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND …
BOSTON, Jan. 20, 2022 /PRNewswire/ -- Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today …See details»
Oxeia Biopharmaceuticals, Inc. | Insights
Jun 3, 2021 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
oxeiabiopharma.com Reviews: Is this site a scam or legit?
Is oxeiabiopharma.com legit? It's likely. The oxeiabiopharma.com website earned a medium authoritative trust score from our website Validator. We put to work 53 powerful factors to …See details»
News Release: OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW …
Boston, MA, January 20, 2022 – Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today announced two …See details»
OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 …
Aug 3, 2022 Phase 2 clinical trial for OXE103 for the treatment of concussion is being conducted at University of Kansas Medical Center, Kansas City, Kansas; Enrolling highly symptomatic …See details»
What We Do - Oxeia Biopharmaceuticals
Oxeia is developing treatments for mild traumatic brain injury, injuries that otherwise can lead to a life-time of debilitating symptoms and other neurologic consequences.See details»
Oxeia Biopharma In the News — Oxeia Biopharmaceuticals
Jun 10, 2024 Oxeia’s CEO, Dr. Michael Wyand, spoke to a local Massachusetts audience, the NB Science Cafe, about "Clinical Trials for Concussion; A Critical Unmet Medical Need.”See details»